Famciclovir: Clinical Trials

22 trials of Famciclovir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 8 Phase 3, 5 Phase 4, 4 Not applicable, 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 38Completed 7, Terminated 1
Phase 45Completed 4, Recruiting 1
Not applicable4Completed 2, Not yet recruiting 1, Unknown 1
Phase 23Completed 2, Unknown 1
Phase 12Completed 2

Follow Famciclovir: new trials by email Literature Review of Famciclovir trials Research Report on Famciclovir

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster
Brivudine, Famciclovir - Herpes Zoster
Phase 4RecruitingPeking University Third Hospital1402025-08-252026-01-02
Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain
Ultrasound-Guided Pulsed Radiofrequency (PRF), Intercostal nerve block (2% ropivacaine or 133 mg of liposomal bupivacaine), Paravertebral (PVB) Block (2% ropivacaine or 133 mg of liposomal bupivacaine) - Herpes Zoster (HZ)
Not applicableNot yet recruitingXiaguang Duan1202025-02-012025-01-29
Effect of Mechanical Ventilation on Radiofrequency Ablation in Atrial Fibrillation
Radiofrequency Ablation with FCV., Radiofrequency Ablation with VCV. - Radiofrequency Ablation, Atrial Fibrillation
RecruitingKocaeli City Hospital502025-01-012025-01-24
Famciclovir in Multiple Sclerosis
Famciclovir - Multiple Sclerosis
Phase 2UnknownQueen Mary University of London302020-11-252022-03-17
Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia
Oxycodone, Gabapentin, Famciclovir - Herpes Zoster, Post-herpetic Neuralgia
Not applicableUnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine1402017-05-012017-04-19
Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes
Famciclovir, Aciclovir - GENITAL HERPES
Phase 3CompletedEMS1502012-07-012021-04-21
Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster
Famciclovir, Aciclovir - Herpes Zoster
Phase 3CompletedEMS1772012-06-012019-04-17
Famvir for Treatment of Hearing in Unilateral Meniere's Disease
Famciclovir, Placebo - Meniere's Disease
Phase 3TerminatedHouse Research Institute112011-12-012021-04-19
Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
Famciclovir - Herpes Labialis
Phase 2 / Phase 3CompletedNovartis Pharmaceuticals532009-03-252021-06-25
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
famciclovir - Herpes Simplex
Phase 2CompletedNovartis182007-10-012011-02-11
Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions
famciclovir - Herpes
Not applicableCompletedRoxane Laboratories362007-07-012018-01-23
Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions
famciclovir - Herpes
Not applicableCompletedRoxane Laboratories312007-07-012018-01-23
Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients
Famciclovir, Placebo - Genital Herpes
Phase 4CompletedNovartis4632007-06-012011-03-28
Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
Famciclovir, Valacyclovir, Placebo matching famciclovir - Genital Herpes
Phase 3CompletedNovartis Pharmaceuticals11792006-03-012011-06-30
Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
famciclovir - Chickenpox, Herpes Zoster
Phase 3CompletedNovartis762005-07-012007-09-26
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
Famciclovir - Herpes Simplex
Phase 3CompletedNovartis Pharmaceuticals742005-02-012013-04-25
Famciclovir 500 mg Tablets Under Non-Fasting Conditions
Famciclovir 500 mg Tablets, Famvir® 500 mg Tablets - Healthy
Phase 1CompletedTeva Pharmaceuticals USA362004-08-012024-08-20
Famciclovir 500 mg Tablets Under Fasting Conditions
Famciclovir 500 mg Tablets, Famvir® 500 mg Tablets - Healthy
Phase 1CompletedTeva Pharmaceuticals USA362004-08-012024-08-20
A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding
Famciclovir - Genital Herpes
Phase 4CompletedNovartis2004-07-012012-04-27
A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis
Famciclovir - Recurrent Herpes Labialis
Phase 4CompletedNovartis2003-10-012007-12-10

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Herpes Simplex (7)  ·  Herpes Genitalis (6)  ·  Herpes Zoster (5)  ·  Herpes Labialis (3)  ·  Atrial Fibrillation (1)  ·  Chickenpox (1)  ·  Hearing Loss (1)  ·  Meniere Disease (1)  ·  Multiple Sclerosis (1)  ·  Neuralgia, Postherpetic (1)  ·  Pain (1)  ·  Pathologic Complete Response (1)  ·  Tinnitus (1)  ·  Vertigo (1)

Sponsors

Novartis (7)  ·  Novartis Pharmaceuticals (3)  ·  EMS (2)  ·  Roxane Laboratories (2)  ·  Teva Pharmaceuticals USA (2)  ·  House Research Institute (1)  ·  Kocaeli City Hospital (1)  ·  Peking University Third Hospital (1)  ·  Queen Mary University of London (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Xiaguang Duan (1)

Countries

United States (12)  ·  Canada (3)  ·  Australia (2)  ·  Brazil (2)  ·  China (2)  ·  Panama (2)  ·  Costa Rica (1)  ·  Germany (1)  ·  Guatemala (1)  ·  South Africa (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Irwin Plisco, M.D. (2)  ·  Benno G Roesch, M.D. (1)  ·  Dalu Mohammed, Dr (1)  ·  Dr. Jeffery L. Blumer (1)  ·  Jennifer Derebery, MD (1)  ·  Joyce Silva, MD (1)  ·  Roberto Amazonas, MD (1)

Results publications

PMID 19273678, PMID 18621575, PMID 19192993, PMID 19195785, PMID 20070143, PMID 20160046, PMID 21178655, PMID 29746903, PMID 38131621